市場調查報告書
商品編碼
1452942
全球醫療保健延展實境市場 2024-2031Global Healthcare Extended Reality Market 2024-2031 |
全球醫療保健延展實境市場預計在預測期內(2024-2031 年)將以 16.2% 的CAGR成長。最近的全球健康危機尤其加劇了對遠距醫療諮詢的需求不斷成長,對先進培訓方法的需求以及醫療機構對極限編程(XP)技術的投資不斷增加是推動市場成長的一些主要因素。此外,遠距醫療技術的進步正在對醫療保健領域的延展實境領域產生積極影響。然而,由於設備成本高且缺乏醫療保健環境中使用的標準化法規,市場也面臨挑戰。
全球醫療保健延展實境市場按組件、技術、應用程式和最終用戶進行細分。根據組件,市場分為軟體和服務以及硬體。根據技術,市場分為 AR、VR 和 MR。根據應用,市場細分為醫療培訓和教育、手術規劃、復健和治療以及患者護理和監測。此外,根據最終用戶,市場細分為醫院、診所和外科中心、製藥和生物技術公司、研究組織和診斷實驗室以及政府和國防機構。在最終用戶中,醫院、診所和外科中心細分市場預計將佔據相當大的市場佔有率。考慮到醫療流程和患者互動的範圍和多樣性,延展實境技術提供了顯著的好處。這提高了手術準確性,加快了診斷過程,並提高了患者參與度。醫療保健組織對延展實境技術的投資將在未來幾年內成長,進一步鞏固其作為主要最終用戶的角色。
在這些技術中,AR細分市場預計將在醫療保健延展實境市場中佔據相當大的佔有率。 AR 對於需要即時資料疊加的手術(例如手術和診斷)變得越來越重要。它為醫療保健提供者提供了降低風險和減輕認知負擔等好處。頭戴式顯示器和智慧眼鏡等穿戴式技術透過在工人完成活動時向他們提供資料和虛擬指令,提供了一種免持工作方式。透過使用 AR 技術可以提高醫療流程的效率,因為基於 AR 的影像視覺化可以幫助外科醫生並提高複雜手術期間的準確性和精確度。例如,2023 年 12 月,Augmedics 宣布有 5,000 名患者接受了 xvision 脊椎系統治療。兩者都是第一個獲得 FDA 手術批准的 AR 導航系統,也是第一個在美國用於手術的 AR 導航系統。
全球醫療保健延展實境市場根據地理位置進一步細分,包括北美(美國和加拿大)、歐洲(英國、義大利、西班牙、德國、法國和歐洲其他地區)、亞太地區(印度、中國、日本、韓國和亞洲其他地區)以及世界其他地區(中東和非洲以及拉丁美洲)。其中,由於醫療基礎設施的改善,預計亞太地區將在全球市場中佔據顯著佔有率。中國、印度和日本等新興經濟體為醫療保健產業 AR 和 VR 技術的開發和分銷相關的外包服務提供了相當吸引人的選擇。
在所有地區中,由於北美地區強大的醫療基礎設施、研發活動投資、有利的政府舉措以及對技術的大量投資,預計北美地區在預測期內將以相當大的CAGR成長。此外,該地區領先的延展實境和醫療保健技術公司的存在也促進了市場的成長。用於神經外科和胸腔外科的先進 VR 工具,使外科醫生能夠在執行手術之前虛擬地探索患者的大腦和身體。它使外科醫生能夠在執行手術之前虛擬地探索患者的解剖結構。此外,VR 是一種較新的分散注意力的形式,可能已在兒科環境中使用,以減輕接受針靜脈注射手術的兒童的疼痛和恐懼。例如,加拿大聖地兄弟會兒童醫院經過四年的研究,於 2023 年 3 月將 VR 融入其護理流程。這種互動技術的使用使孩子們可以在接受醫療手術時使用虛擬實境,減少他們可能經歷的焦慮或疼痛。透過持續努力,醫院可以在 2024 年為約 3,500 名患者提供 VR,並在未來 5 年內為多達 17,500 名患者提供 VR。
服務於全球醫療保健延展實境市場的主要公司包括索尼公司、Magic Leap、美敦力、Surgical Theater, Inc.、Osso VR、AppliedVR、BioflightVR、Fundamentalurgery、Fusion VR、GIGXR、Medicalholodeck、PrecisionOS、SphereGen Technologies LLC、XRHealth Technologies LLC、XR、PrecisionOS和別的。市場參與者透過各種策略(包括併購、合作、合作、融資和新產品發布),為市場成長做出了巨大貢獻,以保持市場競爭力。例如,2021 年 1 月,Hologic, Inc. 以約 2.3 億美元收購了 Biotheranostics, Inc.,這是一家私人持有的商業階段公司,為乳腺癌和轉移性癌症提供分子診斷測試。透過收購 Biotheranostics,Hologic, Inc. 可能會將其合資企業推向規模龐大且迅速擴張的腫瘤學領域,這與其更大的公司目標一致。
Global Healthcare Extended Reality Market Size, Share & Trends Analysis Report by Component (Software & Services and Hardware), by Technology (Augmented Reality (AR), Virtual Reality (VR), and Mixed Reality (MR)), and by Application (Medical Training and Education, Surgical Planning, Rehabilitation & Therapy, and Patient Care & Monitoring), and by End-User (Hospitals, Clinics & Surgical Centers, Pharmaceutical & Biotechnology Companies, Research Organization & Diagnostics Laboratories, and Government & Defense Institutions) Forecast Period (2024-2031)
The global healthcare extended reality market is anticipated to grow at a CAGR of 16.2% during the forecast period (2024-2031). The rising need for remote medical consultations is especially accentuated by recent global health crises, the need for advanced training methods, and the growing investments in Extreme Programming (XP) technology by healthcare organizations are some of the major factors contributing to the market growth. Additionally, advances in telemedicine technologies are positively affecting the extended reality sector within healthcare. However, the market also faces challenges due to the high cost of devices and the lack of standardized regulations for their use in healthcare settings.
The global healthcare extended reality market is segmented by component, technology, application, and end-user. Based on the component, the market is sub-segmented into software & services, and hardware. Based on the technology, the market is sub-segmented into AR, VR, and MR. Based on the applications, the market is sub-segmented into medical training and education, surgical planning, rehabilitation and therapy, and patient care & monitoring. Further, based on the end-users, the market is sub-segmented into hospitals, clinics & surgical centers, pharmaceutical & biotechnology companies, research organizations and diagnostics laboratories, and government & defense institutions. Among the end-users, the hospitals, clinics, and surgical centers sub-segment is anticipated to hold a considerable share of the market. Extended reality technologies provide significant benefits considering the scope and diversity of medical processes and patient interactions. This increases surgical accuracy, expedites diagnostic processes, and improves patient engagement. Investments in extended reality technologies by healthcare organizations are set to grow in the coming years, further solidifying their role as the primary end-users.
Among the technology, the AR sub-segment is expected to hold a considerable share of the healthcare extended reality market. AR is becoming increasingly crucial for procedures that require real-time overlays of data, such as surgeries and diagnostics. It offers benefits such as reduced risk and less cognitive load for healthcare providers. Wearable technology, such as head-mounted displays and smart glasses, provide a hands-free approach to perform work by providing data and virtual instructions to workers as they complete activities. The efficiency of healthcare processes can be enhanced by using AR technologies as AR-based image visualization assists surgeons and enhances their accuracy and precision during complex surgeries. For instance, in December 2023, Augmedics announced 5,000 patients treated with its xvision Spine System. Both were the first AR navigation systems to gain FDA approval for surgery and the first to be used in surgery in the US.
The global healthcare extended reality market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to the improving healthcare infrastructure. Emerging economies such as China, India and Japan present attractive options for outsourcing services associated with the development and distribution of AR and VR technology in the healthcare industry.
Among all regions, the North American region is anticipated to grow at a considerable CAGR over the forecast period due to its robust healthcare infrastructure, investment in R&D activities, favorable government initiatives, and significant investments in technology. Additionally, the presence of leading extended reality and healthcare technology companies in the region boosting the market growth. Advanced VR tool for neurosurgery and thoracic surgery, enables surgeons to virtually explore a patient's brain and body before performing a procedure. It enables surgeons to virtually explore a patient's anatomy prior to performing a procedure. Furthermore, VR is a more recent form of distraction that may have been used in the pediatric setting for reducing pain and fear in children undergoing needle-based intravenous procedures. For instance, in March 2023, Shriners Hospitals for Children Canada integrated VR into its care processes after four years of research. The use of this interactive technology allows children to use VR, while undergoing medical procedures reducing anxiety or pain they may experience. With sustained efforts, the hospitals could offer VR to approximately 3,500 patients in 2024 and up to 17,500 patients over the next 5 years.
The major companies serving the global healthcare extended reality market include Sony Corporation, Magic Leap, Medtronic, Surgical Theater, Inc., Osso VR, AppliedVR, BioflightVR, Fundamental Surgery, Fusion VR, GIGXR, Medicalholodeck, PrecisionOS, SphereGen Technologies LLC, XRHealth, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in January 2021, Hologic, Inc. acquired Biotheranostics, Inc., a privately held, commercial-stage Company that provides molecular diagnostic tests for breast and metastatic cancers, for approximately $230 million. By acquiring Biotheranostics, Hologic, Inc. may launch its venture into a sizable and rapidly expanding oncology adjacency, which aligns with their larger company objectives.